Literature DB >> 15059777

Effects of the taxanes paclitaxel and docetaxel on edema formation and interstitial fluid pressure.

Aurora Brønstad1, Ansgar Berg, Rolf K Reed.   

Abstract

Interstitial fluid pressure (P(if)) is important for maintaining constant interstitial fluid volume. In several acute inflammatory reactions, a dramatic lowering of P(if) has been observed, increasing transcapillary filtration pressure and favoring initial and rapid edema formation. This lowering of P(if) seems to involve dynamic beta(1)-integrin-mediated interactions between connective tissue cells and extracellular matrix (ECM) fibers. beta(1)-Integrins are adhesion receptors responsible for the attachment of connective tissue cells to the ECM providing a force-transmitting physical link between the ECM and cytoskeleton. Disruption of actin filaments leads to lowering of P(if) and edema formation, suggesting a role for actin filaments. The aim of this study was to further investigate the role of the cytoskeleton in the control of P(if) by studying the effect of microtubuli fixation using paclitaxel and docetaxel. P(if) was measured with the micropuncture technique. Albumin extravasation (E(alb)) was measured using (125)I-labeled albumin. Paclitaxel and docetaxel were tested locally on foot skin in female Wistar rats. Paclitaxel (6 mg/ml) reduced P(if) from -1.5 +/- 1.0 mmHg in controls to -4.9 +/- 2.6 mmHg after 30 min (P < 0.05) in a dose-dependent manner (P < 0.05). Docetaxel caused a similar lowering of P(if). Both paclitaxel and docetaxel increased E(alb) compared with Cremophor EL and saline control (P < 0.05). Pretreatment with phalloidin before paclitaxel, causing fixation of actin filaments, abolished the lowering of P(if) caused by paclitaxel. This study confirms several previous studies demonstrating that connective tissue cells influence P(if) and edema formation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15059777     DOI: 10.1152/ajpheart.01052.2003

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  12 in total

1.  Hyperelastic modeling of swelling in fibrous soft tissue with application to tracheal angioedema.

Authors:  Kun Gou; Thomas J Pence
Journal:  J Math Biol       Date:  2015-05-21       Impact factor: 2.259

Review 2.  Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.

Authors:  Tessa C Gillespie; Hoda E Sayegh; Cheryl L Brunelle; Kayla M Daniell; Alphonse G Taghian
Journal:  Gland Surg       Date:  2018-08

3.  Risk Factors for Lymphedema in Breast Cancer Survivors Following Axillary Lymph Node Dissection.

Authors:  Yoshiteru Akezaki; Ritsuko Tominaga; Masato Kikuuchi; Hideaki Kurokawa; Makiko Hamada; Kenjiro Aogi; Shozo Ohsumi; Tetsuya Tsuji; Susumu Kawamura; Shinsuke Sugihara
Journal:  Prog Rehabil Med       Date:  2019-11-23

4.  Transient swelling versus lymphoedema in the first year following surgery for breast cancer.

Authors:  Sharon L Kilbreath; Mi-Joung Lee; Kathryn M Refshauge; Jane M Beith; Leigh C Ward; J M Simpson; D Black
Journal:  Support Care Cancer       Date:  2013-03-15       Impact factor: 3.603

5.  Single-eye trial of a topical carbonic anhydrase inhibitor versus intravitreal bevacizumab for the treatment of taxane drug-induced cystoid macula oedema.

Authors:  Mark M Hassall; Nicholas Howard Andrew
Journal:  BMJ Case Rep       Date:  2016-04-19

6.  Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort.

Authors:  Meyha N Swaroop; Chantal M Ferguson; Nora K Horick; Melissa N Skolny; Cynthia L Miller; Lauren S Jammallo; Cheryl L Brunelle; Jean A O'Toole; Steven J Isakoff; Michelle C Specht; Alphonse G Taghian
Journal:  Breast Cancer Res Treat       Date:  2015-05-05       Impact factor: 4.872

Review 7.  Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid.

Authors:  Gianfranco Baronzio; Gurdev Parmar; Miriam Baronzio
Journal:  Front Oncol       Date:  2015-07-23       Impact factor: 6.244

8.  Nanoparticulated docetaxel exerts enhanced anticancer efficacy and overcomes existing limitations of traditional drugs.

Authors:  Jinhyang Choi; Eunjung Ko; Hye-Kyung Chung; Jae Hee Lee; Eun Jin Ju; Hyun Kyung Lim; Intae Park; Kab-Sig Kim; Joo-Hwan Lee; Woo-Chan Son; Jung Shin Lee; Joohee Jung; Seong-Yun Jeong; Si Yeol Song; Eun Kyung Choi
Journal:  Int J Nanomedicine       Date:  2015-09-29

Review 9.  Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents.

Authors:  Marta Cesca; Francesca Bizzaro; Massimo Zucchetti; Raffaella Giavazzi
Journal:  Front Oncol       Date:  2013-10-01       Impact factor: 6.244

10.  A randomized cross-over trial to detect differences in arm volume after low- and heavy-load resistance exercise among patients receiving adjuvant chemotherapy for breast cancer at risk for arm lymphedema: study protocol.

Authors:  Kira Bloomquist; Sandi Hayes; Lis Adamsen; Tom Møller; Karl Bach Christensen; Bent Ejlertsen; Peter Oturai
Journal:  BMC Cancer       Date:  2016-07-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.